GSK’s ViiV healthcare unit is countering rival HIV drugmaker Gilead’s recent global access moves with its own pledge to make at least 2 million doses of its long-acting pre-exposure prophylaxis (Pr | ...

Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the drugmaker to make changes ...

The safety review was requested by the French medicines agency, citing new safety reports that alter the risk profile of ...

Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

Pfizer sold 640 million shares in Haleon for 380p each, reducing its holding in the consumer healthcare firm by 7.6% ...

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

FTSE 100 Live 01 October Mulberry rejects Frasers bid approachGreggs' sales jump, shares fallMarket activity slows - ...

Pfizer Inc. ($PFE) has sold its stake worth $3.26 billion in UK-based consumer healthcare company Haleon PLC ($GB:HLN). With ...

An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...

GSK and Pfizer’s full-year financial results ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns ...

Mpox – formerly known as monkeypox – is rapidly spreading in several African countries, prompting the World Health ...

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals ... Company has reported net profit after tax of Rs 182.33 Crore in latest quarter.The company’s top ...